Merkel Cell Carcinoma of the External Ear: Population-Based Analysis and Survival Outcomes.
André S AlvesMatteo ScampaJérôme MartineauSalvatore GiordanoDaniel Felix KalbermattenCarlo Maria OrangesPublished in: Cancers (2022)
(1) Background : Due to its highly aggressive behavior, the ability to identify and manage Merkel Cell Carcinoma (MCC) with a full understanding of its characteristics is essential. Because the external ear is an exposed area, resection can have dramatic consequences on patient's self-image, which is why it is fundamental to detect MCC, typically found on UV-exposed regions such as the ears, at an early stage. (2) Methods : The Surveillance, Epidemiology, and End Results (SEER) database was searched for all external ear MCC between 2000 and 2019. A descriptive analysis based on frequencies was made to describe the demography of pathophysiologic features linked to MCC. Overall survival (OS) was studied and compared between variables with a log rank test. A multivariable Cox regression analysis was then computed to identify independent prognostic factors. (3) Results : A total of 210 patients (160 men) were identified with a median age of 80 years. The median OS was 47 months. Factors associated with lower OS included an age of over 80 years, the male gender, a tumor size of >5 cm, and metastatic disease. Gross (<1 cm) and wide (>1 cm) surgery excision margins were the surgery types with the best OS. (4) Conclusions : MCC of the external ear is diagnosed mostly in old men. Among the 182 patients who received a surgical procedure, gross and wide excision without radiotherapy were associated with the best OS.
Keyphrases
- prognostic factors
- early stage
- minimally invasive
- small cell lung cancer
- public health
- squamous cell carcinoma
- emergency department
- coronary artery bypass
- newly diagnosed
- machine learning
- ejection fraction
- computed tomography
- coronary artery disease
- magnetic resonance
- lymph node
- deep learning
- radiation induced
- sentinel lymph node
- atrial fibrillation
- percutaneous coronary intervention
- electronic health record
- rectal cancer
- peritoneal dialysis
- adverse drug
- data analysis
- contrast enhanced